Final compound dilution occurs post-injection giving a final concentration of 50, 35, 25, 12.5, 10 and 5 M inside the well
Product Specifications Compound: Tesamorelin CAS: 218949-48-5 Form: Lyophilized Powder Appearance: White to off-white powder Unit Size: 10mg Purity: 99% (HPLC verified) Container: Sterile Glass Vial Intended Use: In Vitro Research Only Research Background Tesamorelin has been referenced within scientific literature and laboratory investigations involving molecular characterization, analytical testing, and controlled research applications
Youre not supplementing something your body doesnt make
Discussion The described revision of Paglia and Valentine [1] method to evaluate GP activity in RBCs membranes of mammalia must be optimized for the specific kind of samples studied
IM stays elevated for slightly longer at the injection site
Anyone translating trial doses into vial concentrations for study purposes should treat the numbers strictly as reference points